Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T35827L |
PKCε Inhibitor Peptide acetate
PKCε Inhibitor Peptide acetate(182683-50-7 Free base) |
PKC | Chromatin/Epigenetic; Cytoskeletal Signaling |
PKCε Inhibitor Peptide acetate 是一种特异性 PKCε 抑制剂,含有其特定受体活化 C 激酶 (RACK) 的位点。 PKCε Inhibitor Peptide acetate 抑制 PKCε 的转运,但不抑制 αPKC,βPKC 和 δPKC 的转运。 | |||
T35827 |
Epsilon-V1-2
PKCε Inhibitor Peptide,Protein Kinase Cɛ Inhibitor Peptide,ɛV1-2 |
||
Protein kinase C (PKC ) is a calcium-independent, phospholipid- and diacylglycerol-dependent serine/threonine kinase involved in diverse signaling pathways, including those involved in neuronal signaling, cytoskeletal function, and inflammation.[1] PKC inhibitor peptide is a synthetic peptide corresponding to an amino acid sequence found in the amino terminal C2 domain of most mammalian forms of PKC .[2] It selectively and reversibly inhibits the translocation of PKC to intracellular membrane... | |||
T80511 |
PKCε inhibitor peptide,myristoylated
Myr‐PKCɛ- |
PKC | Chromatin/Epigenetic; Cytoskeletal Signaling |
Myristoylated PKCε inhibitor peptide(Myr-PKCε-)是一种与肉豆蔻酸偶联、具有细胞渗透性的PKCε蛋白激酶Cε亚型特异性肽抑制剂,它能够降低人脐静脉内皮细胞(HUVECs)的一氧化氮(NO)释放。 | |||
T81450 |
PKCε Inhibitor Scramble Peptide
|
||
PKCε Inhibitor Scramble Peptide为一Scramble肽,其氨基酸序列与PKCε抑制肽相同。 | |||
T81449 |
PKC-ε translocation inhibitor peptide
|
PKC | Chromatin/Epigenetic; Cytoskeletal Signaling |
PKC-ε translocation inhibitor peptide,作为一种特定的PKC-ε易位抑制剂,能够特异性地调控FcγR介导的调理珠内化速率,而对FcαR运输不产生影响。 | |||
T80507 |
PKCθ pseudosubstrate peptide inhibitor,myristoylated
|
PKC | Chromatin/Epigenetic; Cytoskeletal Signaling |
Myristoylated PKCθ pseudosubstrate peptide inhibitor 是一款合成肽,专门用于研究 PKCθ 的机制。 | |||
T80070 |
PKCβII Peptide Inhibitor I
|
PKC | Chromatin/Epigenetic; Cytoskeletal Signaling |
PKCβII Peptide Inhibitor I 为一种特定的PKCβII抑制剂。在大鼠心脏缺血/再灌注损伤模型中,该化合物显著表现出心脏保护效应,并能有效预防血管内皮功能障碍。 | |||
T80505 |
PKCα (C2-4) inhibitor peptide
|
PKC | Chromatin/Epigenetic; Cytoskeletal Signaling |
PKCα(C2-4) inhibitor peptide为专一性PKCα抑制剂,能够抑制α1A‐肾上腺素受体激动剂A-61603对IKr通道的影响。 |